Literature DB >> 33243890

Precise T cell recognition programs designed by transcriptionally linking multiple receptors.

Jasper Z Williams1,2,3, Greg M Allen1,2,3,4, Devan Shah1,2,3, Igal S Sterin1,2,3, Ki H Kim1,2,3, Vivian P Garcia1,2,3, Gavin E Shavey1,2,3, Wei Yu1,2,3, Cristina Puig-Saus5, Jennifer Tsoi5, Antoni Ribas5, Kole T Roybal1,2,3, Wendell A Lim6,2,3,7.   

Abstract

Living cells often identify their correct partner or target cells by integrating information from multiple receptors, achieving levels of recognition that are difficult to obtain with individual molecular interactions. In this study, we engineered a diverse library of multireceptor cell-cell recognition circuits by using synthetic Notch receptors to transcriptionally interconnect multiple molecular recognition events. These synthetic circuits allow engineered T cells to integrate extra- and intracellular antigen recognition, are robust to heterogeneity, and achieve precise recognition by integrating up to three different antigens with positive or negative logic. A three-antigen AND gate composed of three sequentially linked receptors shows selectivity in vivo, clearing three-antigen tumors while ignoring related two-antigen tumors. Daisy-chaining multiple molecular recognition events together in synthetic circuits provides a powerful way to engineer cellular-level recognition.
Copyright © 2020, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33243890      PMCID: PMC8054651          DOI: 10.1126/science.abc6270

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

1.  Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.

Authors:  Richard A Morgan; James C Yang; Mio Kitano; Mark E Dudley; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells.

Authors:  Eugenia Zah; Meng-Yin Lin; Anne Silva-Benedict; Michael C Jensen; Yvonne Y Chen
Journal:  Cancer Immunol Res       Date:  2016-04-08       Impact factor: 11.151

3.  Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.

Authors:  Sandeep Nambiar; Alireza Mirmohammadsadegh; Roya Doroudi; Annett Gustrau; Alessandra Marini; Gernot Roeder; Thomas Ruzicka; Ulrich R Hengge
Journal:  Arch Dermatol       Date:  2005-02

4.  Designed protein logic to target cells with precise combinations of surface antigens.

Authors:  Marc J Lajoie; Scott E Boyken; Alexander I Salter; Jilliane Bruffey; Anusha Rajan; Robert A Langan; Audrey Olshefsky; Vishaka Muhunthan; Matthew J Bick; Mesfin Gewe; Alfredo Quijano-Rubio; JayLee Johnson; Garreck Lenz; Alisha Nguyen; Suzie Pun; Colin E Correnti; Stanley R Riddell; David Baker
Journal:  Science       Date:  2020-08-20       Impact factor: 47.728

5.  De novo design of protein logic gates.

Authors:  Zibo Chen; Ryan D Kibler; Andrew Hunt; Florian Busch; Jocelynn Pearl; Mengxuan Jia; Zachary L VanAernum; Basile I M Wicky; Galen Dods; Hanna Liao; Matthew S Wilken; Christie Ciarlo; Shon Green; Hana El-Samad; John Stamatoyannopoulos; Vicki H Wysocki; Michael C Jewett; Scott E Boyken; David Baker
Journal:  Science       Date:  2020-04-03       Impact factor: 47.728

6.  Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

Authors:  Laura A Johnson; Richard A Morgan; Mark E Dudley; Lydie Cassard; James C Yang; Marybeth S Hughes; Udai S Kammula; Richard E Royal; Richard M Sherry; John R Wunderlich; Chyi-Chia R Lee; Nicholas P Restifo; Susan L Schwarz; Alexandria P Cogdill; Rachel J Bishop; Hung Kim; Carmen C Brewer; Susan F Rudy; Carter VanWaes; Jeremy L Davis; Aarti Mathur; Robert T Ripley; Debbie A Nathan; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-18       Impact factor: 22.113

7.  Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.

Authors:  Jennifer Tsoi; Lidia Robert; Kim Paraiso; Carlos Galvan; Katherine M Sheu; Johnson Lay; Deborah J L Wong; Mohammad Atefi; Roksana Shirazi; Xiaoyan Wang; Daniel Braas; Catherine S Grasso; Nicolaos Palaskas; Antoni Ribas; Thomas G Graeber
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 38.585

8.  The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity.

Authors:  Fiona C Thistlethwaite; David E Gilham; Ryan D Guest; Dominic G Rothwell; Manon Pillai; Deborah J Burt; Andrea J Byatte; Natalia Kirillova; Juan W Valle; Surinder K Sharma; Kerry A Chester; Nigel B Westwood; Sarah E R Halford; Stephen Nabarro; Susan Wan; Eric Austin; Robert E Hawkins
Journal:  Cancer Immunol Immunother       Date:  2017-06-28       Impact factor: 6.968

9.  Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors.

Authors:  Leonardo Morsut; Kole T Roybal; Xin Xiong; Russell M Gordley; Scott M Coyle; Matthew Thomson; Wendell A Lim
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

10.  Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression.

Authors:  P G Natali; M R Nicotra; M F Di Renzo; M Prat; A Bigotti; R Cavaliere; P M Comoglio
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

View more
  29 in total

1.  The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets.

Authors:  Zhongyi Hu; Jiao Yuan; Meixiao Long; Junjie Jiang; Youyou Zhang; Tianli Zhang; Mu Xu; Yi Fan; Janos L Tanyi; Kathleen T Montone; Omid Tavana; Ho Man Chan; Xiaowen Hu; Robert H Vonderheide; Lin Zhang
Journal:  Nat Cancer       Date:  2021-12-13

Review 2.  Engineering living therapeutics with synthetic biology.

Authors:  Andres Cubillos-Ruiz; Tingxi Guo; Anna Sokolovska; Paul F Miller; James J Collins; Timothy K Lu; Jose M Lora
Journal:  Nat Rev Drug Discov       Date:  2021-10-06       Impact factor: 84.694

Review 3.  Rethinking cancer targeting strategies in the era of smart cell therapeutics.

Authors:  Greg M Allen; Wendell A Lim
Journal:  Nat Rev Cancer       Date:  2022-09-29       Impact factor: 69.800

Review 4.  Programmable protein circuit design.

Authors:  Zibo Chen; Michael B Elowitz
Journal:  Cell       Date:  2021-04-12       Impact factor: 41.582

Review 5.  How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors?

Authors:  Adam J Schoenfeld; Roisin E O'Cearbhaill
Journal:  Cancer J       Date:  2021 Mar-Apr 01       Impact factor: 3.360

Review 6.  Strategies for monitoring cell-cell interactions.

Authors:  Tyler J Bechtel; Tamara Reyes-Robles; Olugbeminiyi O Fadeyi; Rob C Oslund
Journal:  Nat Chem Biol       Date:  2021-05-25       Impact factor: 15.040

Review 7.  Synthetic receptors for logic gated T cell recognition and function.

Authors:  Sylvain Simon; Grace Bugos; Alex I Salter; Stanley R Riddell
Journal:  Curr Opin Immunol       Date:  2021-09-24       Impact factor: 7.486

8.  SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma.

Authors:  Joseph H Choe; Payal B Watchmaker; Milos S Simic; Ryan D Gilbert; Aileen W Li; Nira A Krasnow; Kira M Downey; Wei Yu; Diego A Carrera; Anna Celli; Juhyun Cho; Jessica D Briones; Jason M Duecker; Yitzhar E Goretsky; Ruth Dannenfelser; Lia Cardarelli; Olga Troyanskaya; Sachdev S Sidhu; Kole T Roybal; Hideho Okada; Wendell A Lim
Journal:  Sci Transl Med       Date:  2021-04-28       Impact factor: 19.319

9.  T Cells as the Future of Cancer Therapy.

Authors:  Antoni Ribas
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

Review 10.  Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors.

Authors:  Lele Miao; Zhengchao Zhang; Zhijian Ren; Futian Tang; Yumin Li
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.